Hodgkin disease with acute lymphoblastic leukemia.
D000208:Acute Disease; D000293:Adolescent; D003630:Daunorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013431:Sulfates / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D013431:Sulfates; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D015122:Mercaptopurine; D011241:Prednisone; D003630:Daunorubicin